...
ewtx-img

Edgewise Therapeutics Inc, Common Stock

EWTX

NSQ

$29.98

-$0.8

(-2.6%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.91B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
803.52K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.15
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$9 L
$38.12 H
$29.98

About Edgewise Therapeutics Inc, Common Stock

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameEWTXSectorS&P500
1-Week Return-8.29%-0.94%-2.6%
1-Month Return-6.25%-5.08%-1.08%
3-Month Return13.17%-10.62%3.45%
6-Month Return79.41%-6.18%8.57%
1-Year Return214.92%1.98%24.3%
3-Year Return87.02%-0.93%25.58%
5-Year Return-0.07%33.84%84.07%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue123.00K185.00K272.00K538.00K1.73M[{"date":"2019-12-31","value":7.1,"profit":true},{"date":"2020-12-31","value":10.68,"profit":true},{"date":"2021-12-31","value":15.7,"profit":true},{"date":"2022-12-31","value":31.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(123.00K)(185.00K)(272.00K)(538.00K)(1.73M)[{"date":"2019-12-31","value":-12300000,"profit":false},{"date":"2020-12-31","value":-18500000,"profit":false},{"date":"2021-12-31","value":-27200000,"profit":false},{"date":"2022-12-31","value":-53800000,"profit":false},{"date":"2023-12-31","value":-173200000,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses9.92M17.19M43.22M22.08M114.36M[{"date":"2019-12-31","value":8.68,"profit":true},{"date":"2020-12-31","value":15.03,"profit":true},{"date":"2021-12-31","value":37.79,"profit":true},{"date":"2022-12-31","value":19.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(9.92M)(17.19M)(43.22M)(22.08M)(114.36M)[{"date":"2019-12-31","value":-992400000,"profit":false},{"date":"2020-12-31","value":-1719200000,"profit":false},{"date":"2021-12-31","value":-4321500000,"profit":false},{"date":"2022-12-31","value":-2207900000,"profit":false},{"date":"2023-12-31","value":-11435700000,"profit":false}]
Total Non-Operating Income/Expense438.00K138.00K804.00K6.68M28.39M[{"date":"2019-12-31","value":1.54,"profit":true},{"date":"2020-12-31","value":0.49,"profit":true},{"date":"2021-12-31","value":2.83,"profit":true},{"date":"2022-12-31","value":23.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(9.71M)(17.12M)(42.81M)(19.41M)(100.16M)[{"date":"2019-12-31","value":-970500000,"profit":false},{"date":"2020-12-31","value":-1712300000,"profit":false},{"date":"2021-12-31","value":-4281300000,"profit":false},{"date":"2022-12-31","value":-1941500000,"profit":false},{"date":"2023-12-31","value":-10016300000,"profit":false}]
Income Taxes(219.00K)(69.00K)(674.00K)(4.02M)-[{"date":"2019-12-31","value":-21900000,"profit":false},{"date":"2020-12-31","value":-6900000,"profit":false},{"date":"2021-12-31","value":-67400000,"profit":false},{"date":"2022-12-31","value":-401800000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(9.49M)(17.05M)(42.14M)(15.40M)-[{"date":"2019-12-31","value":-948600000,"profit":false},{"date":"2020-12-31","value":-1705400000,"profit":false},{"date":"2021-12-31","value":-4213900000,"profit":false},{"date":"2022-12-31","value":-1539700000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(9.71M)(17.12M)(42.81M)(67.64M)(100.16M)[{"date":"2019-12-31","value":-970500000,"profit":false},{"date":"2020-12-31","value":-1712300000,"profit":false},{"date":"2021-12-31","value":-4281300000,"profit":false},{"date":"2022-12-31","value":-6764000000,"profit":false},{"date":"2023-12-31","value":-10016300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(9.49M)(17.05M)(42.14M)(15.40M)(100.16M)[{"date":"2019-12-31","value":-948600000,"profit":false},{"date":"2020-12-31","value":-1705400000,"profit":false},{"date":"2021-12-31","value":-4213900000,"profit":false},{"date":"2022-12-31","value":-1539700000,"profit":false},{"date":"2023-12-31","value":-10016300000,"profit":false}]
EPS (Diluted)--(5.10)(1.27)(1.58)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-510,"profit":false},{"date":"2022-12-31","value":-127,"profit":false},{"date":"2023-12-31","value":-158,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

EWTX
Cash Ratio 25.98
Current Ratio 26.35

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

EWTX
ROA (LTM) -22.36%
ROE (LTM) -31.90%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

EWTX
Debt Ratio Lower is generally better. Negative is bad. 0.04
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.96

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

EWTX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 5.95
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Edgewise Therapeutics Inc share price today?

Edgewise Therapeutics Inc (EWTX) share price today is $29.98

Can Indians buy Edgewise Therapeutics Inc shares?

Yes, Indians can buy shares of Edgewise Therapeutics Inc (EWTX) on Vested. To buy Edgewise Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EWTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Edgewise Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Edgewise Therapeutics Inc (EWTX) via the Vested app. You can start investing in Edgewise Therapeutics Inc (EWTX) with a minimum investment of $1.

How to invest in Edgewise Therapeutics Inc shares from India?

You can invest in shares of Edgewise Therapeutics Inc (EWTX) via Vested in three simple steps:

  • Click on Sign Up or Invest in EWTX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Edgewise Therapeutics Inc shares
What is Edgewise Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Edgewise Therapeutics Inc (EWTX) is $38.12. The 52-week low price of Edgewise Therapeutics Inc (EWTX) is $9.

What is Edgewise Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Edgewise Therapeutics Inc (EWTX) is

What is Edgewise Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Edgewise Therapeutics Inc (EWTX) is 5.95

What is Edgewise Therapeutics Inc dividend yield?

The dividend yield of Edgewise Therapeutics Inc (EWTX) is 0.00%

What is the Market Cap of Edgewise Therapeutics Inc?

The market capitalization of Edgewise Therapeutics Inc (EWTX) is $2.91B

What is Edgewise Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Edgewise Therapeutics Inc is EWTX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top